Home › Funds › Citadel Advisors › LOGC

Citadel Advisors position in LOGC

LOGICBIO THERAPEUTICS INC

Latest position (Q3 2022)115.92K sh
Reported value held$32.00K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q3 2021 10.90K $50.00K New
Q4 2021 18.60K $43.00K Add
Q1 2022 18.80K $13.00K Add
Q2 2022 21.50K $8.00K Add
Q3 2022 115.92K $32.00K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding LOGC

No other tracked fund reports a position in LOGC.

All LOGC fund holders →